文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

葡聚糖硫酸钠溶液处理小鼠给予白色念珠菌导致肠道菌群失调、肠道铜绿假单胞菌出现并播散及致死性脓毒症

Administration of Candida Albicans to Dextran Sulfate Solution Treated Mice Causes Intestinal Dysbiosis, Emergence and Dissemination of Intestinal Pseudomonas Aeruginosa and Lethal Sepsis.
PubMed 文献 · Shock · 2020-01-01
一句话结论小鼠模型中肠道白色念珠菌通过炎症诱导的肠道通透选择性缺陷引发菌血症并促进铜绿假单胞菌生长,氟康唑减少肠道真菌可减轻病情严重程度。

在3%葡聚糖硫酸钠(DSS)诱导结肠炎小鼠模型中反复口服白色念珠菌,DSS+念珠菌组死亡率升高并出现菌血症(无念珠菌血症),尽管腹泻严重程度与单用DSS组相似。DSS+念珠菌组和单用DSS组粪便优势菌分别为假单胞菌属和肠杆菌属,提示念珠菌诱导肠道菌群失调。DSS+念珠菌组粪便和血液中出现以假单胞菌属为主的氯霉素耐药菌落(单用DSS组无)。从氯霉素耐药菌分离的铜绿假单胞菌给予DSS+念珠菌模型可加重疾病严重程度;用氟康唑减少粪便真菌可降低氯霉素耐药菌负荷并减轻DSS+念珠菌病情严重程度。作者认为针对减少肠道真菌的治疗策略可减轻疾病严重程度。

要点

  • DSS+念珠菌组小鼠死亡率升高并出现菌血症(无念珠菌血症),尽管腹泻严重程度与单用DSS组相似。
  • DSS+念珠菌组粪便优势菌为假单胞菌属,单用DSS组为肠杆菌属,提示念珠菌诱导肠道菌群失调。
  • DSS+念珠菌组粪便和血液中出现以假单胞菌属为主的氯霉素耐药菌落,单用DSS组无。
  • 从氯霉素耐药菌分离的铜绿假单胞菌给予DSS+念珠菌模型可加重疾病严重程度。
  • 用氟康唑减少粪便真菌可降低氯霉素耐药菌负荷并减轻DSS+念珠菌病情严重程度。

适用人群与场景

  • 3%葡聚糖硫酸钠(DSS)诱导结肠炎小鼠模型,反复口服白色念珠菌。

处置流程与药物剂量

  • 用氟康唑减少粪便真菌,可降低氯霉素耐药菌负荷并减轻DSS+念珠菌病情严重程度。

研究设计与关键结果

  • 研究类型为小鼠模型实验;DSS+念珠菌组较单用DSS组死亡率升高并出现菌血症(无念珠菌血症),两组腹泻严重程度相似。
  • DSS+念珠菌组粪便优势菌为假单胞菌属,单用DSS组为肠杆菌属。
  • DSS+念珠菌组粪便和血液中出现以假单胞菌属为主的氯霉素耐药菌落,单用DSS组无。
  • 将鼠粪与DSS及热灭活念珠菌或(1→3)-β-D-葡聚糖共孵育可离体分离出上述抗生素耐药菌,提示细菌在真菌上发酵。
  • 从氯霉素耐药菌分离的铜绿假单胞菌给予DSS+念珠菌模型可加重疾病严重程度;含热灭活念珠菌的血琼脂中分离的铜绿假单胞菌生长增加。
  • 用氟康唑减少粪便真菌可降低氯霉素耐药菌负荷并减轻DSS+念珠菌病情严重程度。

证据类型、等级与局限

  • 证据类型:动物实验(小鼠模型)。
  • 局限:原文未报告局限性;原文结论指出需进一步研究炎症性肠病中的肠道真菌。

对床旁实践的改变

  • 作者认为针对减少肠道真菌的治疗策略可减轻疾病严重程度。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

The influence of gut fungi in chronic colitis was investigated by repeated oral administration of Candida albicans in a 3% dextran sulfate solution (DSS) induced-colitis mouse model. Candida administration in the DSS (DSS+Candida) model enhanced the mortality rate and induced bacteremia (without candidemia) resulting from a gut perm-selectivity defect despite similar diarrheal severity in mice treated with DSS alone. The dominant fecal bacteria in DSS+Candida and DSS alone mice were Pseudomonas spp. and Enterobacter spp., respectively, implying that Candida induced gut dysbiosis. Interestingly, chloramphenicol-resistant bacterial colonies, predominantly Pseudomonas spp., appeared in the feces and blood of DSS+Candida mice (not the DSS alone group) during fungal culture. These antibiotic-resistant bacteria were also isolated, ex vivo, by incubating mouse feces with DSS and heat-killed Candida or (1→3)-β-D-glucan, suggesting bacterial fermentation on fungi. Administration of Pseudomonas aeruginosa isolated from chloramphenicol-resistant bacteria in the DSS+Candida model enhanced the severity of disease, and increased growth of isolated P aeruginosa in blood agar containing heat-killed Candida was demonstrated. These data suggested the selection of a highly virulent bacterial strain following fecal Candida presentation in the gut. Additionally, reduction of fecal fungi with fluconazole decreased the burden of chloramphenicol-resistant bacteria, attenuating the severity of DSS+Candida. In conclusion, gut Candida induced bacteremia in the DSS model through an inflammation-induced gut perm-selectivity defect and facilitated the growth of some gut bacteria. Treatment strategies aimed at reducing gut fungi could attenuate disease severity. Further investigation of gut fungi in inflammatory bowel disease is warranted.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Hiengrach P, Panpetch W, Worasilchai N, et al. Administration of Candida Albicans to Dextran Sulfate Solution Treated Mice Causes Intestinal Dysbiosis, Emergence and Dissemination of Intestinal Pseudomonas Aeruginosa and Lethal Sepsis. Shock. 2020. PMID: 30829903. doi:10.1097/SHK.0000000000001339

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。